Retractable Technologies,Inc. (NYSEMKT:RVP) Files An 8-K Other Events
Item 8.01 Other Events.

On December 6, 2016, Retractable Technologies, Inc. issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, regarding an opinion issued on December 2, 2016 by the Fifth Circuit in Retractable’s case against Becton, Dickinson and Company.

Item 9.01 Financial Statements and Exhibits.

(d)  Exhibits

99 Press release regarding Fifth Circuit opinion.

About Retractable Technologies, Inc. (NYSEMKT:RVP)

Retractable Technologies, Inc. designs, develops and manufactures safety medical products for the healthcare industry. The Company markets VanishPoint and PatientSafe products. The VanishPoint products are designed specifically to prevent needle stick injuries and to prevent reuse. The VanishPoint safety products include tuberculin, insulin and allergy antigen VanishPoint syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL and 10mL VanishPoint syringes, and the VanishPoint autodisable syringe. It also sells the VanishPoint intravenous catheter, the VanishPoint blood collection tube holder and the VanishPoint blood collection set. The PatientSafe syringe reduces the risk of bloodstream infections resulting from catheter hub contamination. Its PatientSafe products include 3mL, 5mL, 10mL, 20mL, 30mL and 60mL syringes, and the PatientSafe Luer cap. Its product designs include retractable needle syringe designs, retractable needle designs and retractable needle dental syringe designs.

Retractable Technologies, Inc. (NYSEMKT:RVP) Recent Trading Information

Retractable Technologies, Inc. (NYSEMKT:RVP) closed its last trading session down -0.07 at 1.17 with 760,953 shares trading hands.